Form D · Biotechnology
Sinobiopharma, Inc.
Nantong City, F4 · CIK 0001403612
Offering snapshot reported Aug 27, 2009 · SEC filing
- Reported sold
- $35K Offering amount: $35K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $35K Reported outside-investor minimum
- First sale
- Jul 14, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2009 | Initial | $35,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133972
Source: Form D, filed Aug 27, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Xuejun Chen | Director, Executive |
| Yuanwei Chen | Director |
| Lequn Lee Huang | Director, Executive |
| Martin Shen | Director |
| Jianguo Wang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8 Zhong Tian Road
Nantong City, F4, 226009
Nantong City, F4, 226009